NCT04516512View on ClinicalTrials.gov

Assessment of SARS-CoV-2 Seroprevalence in Detention

NACompletedINTERVENTIONAL
Enrollment

1,044

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

July 8, 2021

Study Completion Date

July 8, 2021

Conditions
COVID-19
Interventions
BIOLOGICAL

Blood draw

For each participants to the research a peripherical blood draw will be performed

Trial Locations (1)

94275

USMP, Le Kremlin-Bicêtre

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04516512 - Assessment of SARS-CoV-2 Seroprevalence in Detention | Biotech Hunter | Biotech Hunter